ANATARA LIFESCIENCES LTD (ANR)
AI Coverage Rating: Active
ASX AI Signals has generated 3 signal for ANR during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest ANR Signals | |
| 17/06/2026 | BUY |
| 12/06/2026 | SELL |
| 30/04/2026 | SELL |
ANR Share Price | |
| Current Price | $0.010 |
| 52 Week High | $0.017 |
| 52 Week Low: | $0.006 |
| Trading at (% of 52 Week High) | 58.82% |
Business Overview
Anatara Lifesciences Ltd (ASX: ANR) is a healthcare company that develops and commercializes novel therapies aimed at improving gut health in humans and animals. The company focuses on addressing conditions such as gastrointestinal diseases and enhancing animal health through innovative, natural-based solutions.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The BUY signal for ANATARA LIFESCIENCES LTD at a very low price point suggests speculative potential, but the overall confidence remains low due to limited liquidity, potential volatility, and lack of strong fundamental catalysts.
Latest ANATARA LIFESCIENCES LTD(ANR) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial